RetractedArticleFrontiers in physiology2021

MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy by Targeting the sirt1/PGC-1α Pathway.

Runze Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.